These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rate of Pathogenic Germline Variants in Patients With Lung Cancer. Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258 [TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study. Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. Samadder NJ; Riegert-Johnson D; Boardman L; Rhodes D; Wick M; Okuno S; Kunze KL; Golafshar M; Uson PLS; Mountjoy L; Ertz-Archambault N; Patel N; Rodriguez EA; Lizaola-Mayo B; Lehrer M; Thorpe CS; Yu NY; Esplin ED; Nussbaum RL; Sharp RR; Azevedo C; Klint M; Hager M; Macklin-Mantia S; Bryce AH; Bekaii-Saab TS; Sekulic A; Stewart AK JAMA Oncol; 2021 Feb; 7(2):230-237. PubMed ID: 33126242 [TBL] [Abstract][Full Text] [Related]
8. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients. Acevedo F; Walbaum B; Camus M; Manzor M; Muñiz S; Medina L; Petric M; Reyes P; Domínguez F; Puschel K; Merino T; Bravo ML; Pinto MP; Ibáñez C; Hughes K; Sánchez C Breast Cancer Res Treat; 2023 Jun; 199(2):363-370. PubMed ID: 36988750 [TBL] [Abstract][Full Text] [Related]
9. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population. Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661 [TBL] [Abstract][Full Text] [Related]
10. Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program. Jones JC; Golafshar MA; Coston TW; Rao R; Wysokinska E; Johnson E; Esplin ED; Nussbaum RL; Heald B; Klint M; Barrus K; Uson PL; Nguyen CC; Colon-Otero G; Bekaii-Saab TS; Dronca R; Kunze KL; Samadder NJ Cureus; 2023 Apr; 15(4):e37428. PubMed ID: 37181954 [TBL] [Abstract][Full Text] [Related]
14. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer. Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study. Abdel-Razeq H; Al-Azzam K; Elemian S; Abu-Fares H; Abu Sheikha A; Bani Hani H; Bater R; Sharaf B; Heald B; Esplin ED; Nielsen SM; Alkyam M; Abujamous L; Al-Attary A Mol Genet Genomic Med; 2023 Apr; 11(4):e2125. PubMed ID: 36537080 [TBL] [Abstract][Full Text] [Related]
16. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis. Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906 [TBL] [Abstract][Full Text] [Related]
17. Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years. Desai NV; Yadav S; Batalini F; Couch FJ; Tung NM Cancer; 2021 Mar; 127(6):828-833. PubMed ID: 33146899 [TBL] [Abstract][Full Text] [Related]
18. Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers. Brake DA; Idler BM; Kunze KL; Golafshar MA; Heald B; Young S; Klint M; Barrus K; Esplin ED; Nussbaum RL; Samadder NJ; Hinni ML; Chang BA Laryngoscope; 2023 Dec; 133(12):3378-3388. PubMed ID: 37132629 [TBL] [Abstract][Full Text] [Related]
19. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. De Silva DL; Stafford L; Skandarajah AR; Sinclair M; Devereux L; Hogg K; Kentwell M; Park A; Lal L; Zethoven M; Jayawardana MW; Chan F; Butow PN; James PA; Mann GB; Campbell IG; Lindeman GJ Med J Aust; 2023 May; 218(8):368-373. PubMed ID: 37005005 [TBL] [Abstract][Full Text] [Related]
20. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. Bedrosian I; Somerfield MR; Achatz MI; Boughey JC; Curigliano G; Friedman S; Kohlmann WK; Kurian AW; Laronga C; Lynce F; Norquist BS; Plichta JK; Rodriguez P; Shah PD; Tischkowitz M; Wood M; Yadav S; Yao K; Robson ME J Clin Oncol; 2024 Feb; 42(5):584-604. PubMed ID: 38175972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]